37,166 XNAS Volume
XNAS 17 Mar, 2025 2:01 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Daphne L. Taylor | SVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2025 | 2 | 17 (0%) | 0% | - | Common Stock | |
| Daphne L. Taylor | SVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2025 | 1 | 0 | - | - | Restricted Stock Unit | |
| Daphne L. Taylor | SVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2025 | 2 | 2 | - | - | Restricted Stock Unit | |
| Daphne L. Taylor | SVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2025 | 1 | 18 (0%) | 0% | - | Common Stock | |
| Marvin L. White | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2025 | 8 | 49 (0%) | 0% | - | Common Stock | |
| Marvin L. White | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2025 | 6 | 55 (0%) | 0% | - | Common Stock | |
| Marvin L. White | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2025 | 8 | 8 | - | - | Restricted Stock Unit | |
| Marvin L. White | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2025 | 6 | 0 | - | - | Restricted Stock Unit | |
| Jeffrey G. Lamothe | EVP, COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2025 | 3 | 34 (0%) | 0% | - | Common Stock | |
| Jeffrey G. Lamothe | EVP, COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2025 | 2 | 36 (0%) | 0% | - | Common Stock | |
| Jeffrey G. Lamothe | EVP, COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2025 | 3 | 4 | - | - | Restricted Stock Unit | |
| Jeffrey G. Lamothe | EVP, COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2025 | 2 | 0 | - | - | Restricted Stock Unit | |
| So Young Kwon | SVP, GC, BD & Corp Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2025 | 2 | 23 (0%) | 0% | - | Common Stock | |
| So Young Kwon | SVP, GC, BD & Corp Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2025 | 2 | 0 | - | - | Restricted Stock Unit | |
| So Young Kwon | SVP, GC, BD & Corp Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2025 | 2 | 2 | - | - | Restricted Stock Unit | |
| So Young Kwon | SVP, GC, BD & Corp Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2025 | 2 | 25 (0%) | 0% | - | Common Stock | |
| Daphne L. Taylor | SVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Aug 2024 | 158 | 0 | - | - | Restricted Stock Unit | |
| Daphne L. Taylor | SVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Aug 2024 | 158 | 576 (0%) | 0% | - | Common Stock | |
| Jeffrey G. Lamothe | EVP, COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Aug 2024 | 272 | 1,166 (0%) | 0% | - | Common Stock | |
| Jeffrey G. Lamothe | EVP, COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Aug 2024 | 42 | 41 | - | - | Restricted Stock Unit | |
| Jeffrey G. Lamothe | EVP, COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Aug 2024 | 42 | 894 (0%) | 0% | - | Common Stock | |
| Jeffrey G. Lamothe | EVP, COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Aug 2024 | 272 | 0 | - | - | Restricted Stock Unit | |
| So Young Kwon | SVP, GC, BD & Corp Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Aug 2024 | 213 | 801 (0%) | 0% | - | Common Stock | |
| So Young Kwon | SVP, GC, BD & Corp Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Aug 2024 | 213 | 0 | - | - | Restricted Stock Unit | |
| Daniel J. Abdun-Nabi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 925 | 925 | - | - | Restricted Stock Unit | |
| Zsolt Harsanyi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 925 | 925 | - | - | Restricted Stock Unit | |
| Daphne L. Taylor | SVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 8,550 | 8,550 | - | - | Restricted Stock Unit | |
| Marvin L. White | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 22,325 | 22,325 | - | - | Restricted Stock Unit | |
| John Niederhuber | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 925 | 925 | - | - | Restricted Stock Unit | |
| Jeffrey G. Lamothe | EVP, COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 12,825 | 12,825 | - | - | Restricted Stock Unit | |
| Grady Grant | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 925 | 925 | - | - | Restricted Stock Unit | |
| Barbara Lopez Kunz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 925 | 925 | - | - | Restricted Stock Unit | |
| So Young Kwon | SVP, GC, BD & Corp Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 8,550 | 8,550 | - | - | Restricted Stock Unit | |
| Daniel J. Abdun-Nabi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2024 | 7 | 196 (0%) | 0% | - | Common Stock | |
| Daniel J. Abdun-Nabi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2024 | 81 | 0 | - | - | Restricted Stock Unit | |
| Daniel J. Abdun-Nabi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2024 | 7 | 0 | - | - | Restricted Stock Unit | |
| Daniel J. Abdun-Nabi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2024 | 81 | 277 (0%) | 0% | - | Common Stock | |
| Zsolt Harsanyi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2024 | 81 | 280 (0%) | 0% | - | Common Stock | |
| Zsolt Harsanyi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2024 | 81 | 0 | - | - | Restricted Stock Unit | |
| Zsolt Harsanyi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2024 | 7 | 0 | - | - | Restricted Stock Unit | |
| Zsolt Harsanyi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2024 | 7 | 199 (0%) | 0% | - | Common Stock | |
| John Niederhuber | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2024 | 7 | 0 | - | - | Restricted Stock Unit | |
| John Niederhuber | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2024 | 7 | 136 (0%) | 0% | - | Common Stock | |
| John Niederhuber | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2024 | 81 | 217 (0%) | 0% | - | Common Stock | |
| John Niederhuber | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2024 | 81 | 0 | - | - | Restricted Stock Unit | |
| Grady Grant | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2024 | 7 | 117 (0%) | 0% | - | Common Stock | |
| Grady Grant | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2024 | 81 | 0 | - | - | Restricted Stock Unit | |
| Grady Grant | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2024 | 7 | 0 | - | - | Restricted Stock Unit | |
| Grady Grant | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2024 | 81 | 198 (0%) | 0% | - | Common Stock | |
| Barbara Lopez Kunz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2024 | 81 | 0 | - | - | Restricted Stock Unit | |
| Barbara Lopez Kunz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2024 | 7 | 117 (0%) | 0% | - | Common Stock | |
| Barbara Lopez Kunz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2024 | 81 | 198 (0%) | 0% | - | Common Stock | |
| Barbara Lopez Kunz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2024 | 7 | 0 | - | - | Restricted Stock Unit | |
| So Young Kwon | SVP, GC, BD & Corp Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2024 | 42 | 588 (0%) | 0% | - | Common Stock | |
| So Young Kwon | SVP, GC, BD & Corp Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2024 | 42 | 0 | - | - | Restricted Stock Unit | |
| Daphne L. Taylor | SVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2024 | 3,667 | 16,827 (0%) | 0% | - | Common Stock | |
| Daphne L. Taylor | SVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2024 | 1,584 | 1,583 | - | - | Restricted Stock Unit | |
| Daphne L. Taylor | SVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2024 | 3,667 | 7,333 | - | - | Restricted Stock Unit | |
| Daphne L. Taylor | SVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2024 | 1,584 | 18,411 (0%) | 0% | - | Common Stock | |
| Marvin L. White | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2024 | 12,917 | 57,846 (0%) | 0% | - | Common Stock | |
| Marvin L. White | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2024 | 9,584 | 9,584 | - | - | Restricted Stock Unit | |
| Marvin L. White | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2024 | 12,917 | 25,833 | - | - | Restricted Stock Unit | |
| Marvin L. White | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2024 | 9,584 | 67,430 (0%) | 0% | - | Common Stock | |
| Jeffrey G. Lamothe | EVP, COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2024 | 3,667 | 37,504 (0%) | 0% | - | Common Stock | |
| Jeffrey G. Lamothe | EVP, COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2024 | 5,500 | 33,837 (0%) | 0% | - | Common Stock | |
| Jeffrey G. Lamothe | EVP, COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2024 | 5,500 | 11,000 | - | - | Restricted Stock Unit | |
| Jeffrey G. Lamothe | EVP, COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2024 | 3,667 | 3,667 | - | - | Restricted Stock Unit | |
| So Young Kwon | SVP, GC, BD & Corp Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2024 | 3,667 | 3,667 | - | - | Restricted Stock Unit | |
| So Young Kwon | SVP, GC, BD & Corp Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2024 | 3,667 | 7,333 | - | - | Restricted Stock Unit | |
| So Young Kwon | SVP, GC, BD & Corp Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2024 | 3,667 | 24,042 (0%) | 0% | - | Common Stock | |
| So Young Kwon | SVP, GC, BD & Corp Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2024 | 3,667 | 20,375 (0%) | 0% | - | Common Stock | |
| Taylor Daphne L. | SVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 792 | 0 | - | - | Restricted Stock Unit | |
| Daphne L. Taylor | SVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 792 | 13,160 (0%) | 0% | - | Common Stock | |
| Marvin L. White | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jan 2024 | 4,792 | 0 | - | - | Restricted Stock Unit | |
| Lamothe Jeffrey G. | EVP, COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jan 2024 | 1,833 | 28,337 (0%) | 0% | - | Common Stock | |
| Lamothe G. Jeffrey | EVP, COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jan 2024 | 1,833 | 0 | - | - | Restricted Stock Unit | |
| Marvin L. White | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Jan 2024 | 4,792 | 44,929 (0%) | 0% | - | Common Stock | |
| Daniel J. Abdun-Nabi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Aug 2023 | 3,571 | 8,339 (0%) | 0% | - | Common Stock | |
| Daniel J. Abdun-Nabi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Aug 2023 | 3,571 | 0 | - | - | Restricted Stock Unit | |
| Zsolt Harsanyi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Aug 2023 | 3,571 | 8,475 (0%) | 0% | - | Common Stock | |
| Zsolt Harsanyi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Aug 2023 | 3,571 | 0 | - | - | Restricted Stock Unit | |
| John Niederhuber | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Aug 2023 | 3,571 | 5,682 (0%) | 0% | - | Common Stock | |
| John Niederhuber | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Aug 2023 | 3,571 | 0 | - | - | Restricted Stock Unit | |
| Grady Grant | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Aug 2023 | 3,571 | 0 | - | - | Restricted Stock Unit | |
| Grady Grant | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Aug 2023 | 3,571 | 4,880 (0%) | 0% | - | Common Stock | |
| Barbara Lopez Kunz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Aug 2023 | 3,571 | 0 | - | - | Restricted Stock Unit | |
| Barbara Lopez Kunz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Aug 2023 | 3,571 | 4,880 (0%) | 0% | - | Common Stock | |
| Daphne L. Taylor | SVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Aug 2023 | 6,945 | 6,944 | - | - | Restricted Stock Unit | |
| Daphne L. Taylor | SVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Aug 2023 | 6,945 | 12,368 (0%) | 0% | - | Common Stock | |
| Jeffrey G. Lamothe | EVP, COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Aug 2023 | 1,833 | 26,504 (0%) | 0% | - | Common Stock | |
| Jeffrey G. Lamothe | EVP, COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Aug 2023 | 11,979 | 11,979 | - | - | Restricted Stock Unit | |
| Jeffrey G. Lamothe | EVP, COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Aug 2023 | 11,979 | 24,671 (0%) | 0% | - | Common Stock | |
| Jeffrey G. Lamothe | EVP, COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Aug 2023 | 1,833 | 3,667 | - | - | Restricted Stock Unit | |
| So Young Kwon | SVP, GC, BD & Corp Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Aug 2023 | 9,375 | 9,375 | - | - | Restricted Stock Unit | |
| So Young Kwon | SVP, GC, BD & Corp Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Aug 2023 | 9,375 | 16,708 (0%) | 0% | - | Common Stock | |
| Daniel J. Abdun-Nabi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2023 | 297 | 298 | - | - | Restricted Stock Unit | |
| Daniel J. Abdun-Nabi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2023 | 297 | 4,768 (0%) | 0% | - | Common Stock | |
| Daniel J. Abdun-Nabi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 3,571 | 3,571 | - | - | Restricted Stock Unit | |
| Zsolt Harsanyi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2023 | 297 | 298 | - | - | Restricted Stock Unit | |
| Zsolt Harsanyi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 3,571 | 3,571 | - | - | Restricted Stock Unit | |
| Zsolt Harsanyi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2023 | 297 | 4,904 (0%) | 0% | - | Common Stock | |
| John Niederhuber | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 3,571 | 3,571 | - | - | Restricted Stock Unit | |
| John Niederhuber | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2023 | 297 | 2,111 (0%) | 0% | - | Common Stock | |
| John Niederhuber | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2023 | 297 | 298 | - | - | Restricted Stock Unit | |
| Grady Grant | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2023 | 297 | 298 | - | - | Restricted Stock Unit | |
| Grady Grant | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2023 | 297 | 1,309 (0%) | 0% | - | Common Stock | |
| Grady Grant | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 3,571 | 3,571 | - | - | Restricted Stock Unit | |
| Barbara Lopez Kunz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2023 | 297 | 1,309 (0%) | 0% | - | Common Stock | |
| Barbara Lopez Kunz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2023 | 297 | 298 | - | - | Restricted Stock Unit | |
| Barbara Lopez Kunz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 3,571 | 3,571 | - | - | Restricted Stock Unit | |
| So Young Kwon | SVP, GC, BD & Corp Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2023 | 1,834 | 7,333 (0%) | 0% | - | Common Stock | |
| So Young Kwon | SVP, GC, BD & Corp Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2023 | 1,834 | 1,833 | - | - | Restricted Stock Unit | |
| Daphne L. Taylor | SVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2023 | 1,583 | 3,167 | - | - | Restricted Stock Unit | |
| Daphne L. Taylor | SVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2023 | 11,000 | 11,000 | - | - | Restricted Stock Unit | |
| Daphne L. Taylor | SVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2023 | 11,000 | 11,000 | - | - | Stock Option (right to buy) | |
| Daphne L. Taylor | SVP, CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2023 | 1,583 | 5,423 (0%) | 0% | - | Common Stock | |
| Marvin L. White | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2023 | 9,582 | 19,168 | - | - | Restricted Stock Unit | |
| Marvin L. White | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2023 | 9,582 | 40,137 (0%) | 0% | - | Common Stock | |
| Marvin L. White | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2023 | 38,750 | 38,750 | - | - | Stock Option (right to buy) | |
| Marvin L. White | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2023 | 38,750 | 38,750 | - | - | Restricted Stock Unit | |
| Jeffrey G. Lamothe | EVP, COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2023 | 16,500 | 16,500 | - | - | Restricted Stock Unit | |
| Jeffrey G. Lamothe | EVP, COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2023 | 3,666 | 12,692 (0%) | 0% | - | Common Stock | |
| Jeffrey G. Lamothe | EVP, COO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2023 | 3,666 | 7,334 | - | - | Restricted Stock Unit | |
| Jeffrey G. Lamothe | EVP, COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2023 | 16,500 | 16,500 | - | - | Stock Option (right to buy) | |
| So Young Kwon | SVP, GC, BD & Corp Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2023 | 11,000 | 11,000 | - | - | Stock Option (right to buy) | |
| So Young Kwon | SVP, GC, BD & Corp Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2023 | 3,666 | 5,499 (0%) | 0% | - | Common Stock | |
| So Young Kwon | SVP, GC, BD & Corp Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Mar 2023 | 3,666 | 7,334 | - | - | Restricted Stock Unit | |
| So Young Kwon | SVP, GC, BD & Corp Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2023 | 11,000 | 11,000 | - | - | Restricted Stock Unit | |
| Marvin L. White | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2023 | 4,791 | 30,555 (0%) | 0% | - | Common Stock | |
| Marvin L. White | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2023 | 4,791 | 4,792 | - | - | Restricted Stock Unit | |
| Jeffrey G. Lamothe | CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2023 | 1,834 | 1,833 | - | - | Restricted Stock Unit | |
| Jeffrey G. Lamothe | CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2023 | 1,834 | 9,026 (0%) | 0% | - | Common Stock | |
| Daniel J. Abdun-Nabi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Aug 2022 | 3,571 | 3,571 | - | - | Restricted Stock Unit | |
| Zsolt Harsanyi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Aug 2022 | 3,571 | 3,571 | - | - | Restricted Stock Unit | |
| John Niederhuber | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Aug 2022 | 3,571 | 3,571 | - | - | Restricted Stock Unit | |
| Jeffrey G. Lamothe | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Aug 2022 | 5,500 | 5,500 | - | - | Stock Option (right to buy) | |
| Jeffrey G. Lamothe | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Aug 2022 | 5,500 | 5,500 | - | - | Restricted Stock Unit | |
| Jeffrey G. Lamothe | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Aug 2022 | 23,958 | 23,958 | - | - | Restricted Stock Unit | |
| Grady Grant | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Aug 2022 | 3,571 | 3,571 | - | - | Restricted Stock Unit | |
| Barbara Lopez Kunz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Aug 2022 | 3,571 | 3,571 | - | - | Restricted Stock Unit | |
| So Young Kwon | SVP, GC and Corporate Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Aug 2022 | 18,750 | 18,750 | - | - | Restricted Stock Unit | |
| Marvin L. White | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 28,750 | 28,750 | - | - | Restricted Stock Unit | |
| Jeffrey G. Lamothe | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 11,000 | 11,000 | - | - | Restricted Stock Unit | |
| So Young Kwon | SVP, GC and Corporate Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2022 | 11,000 | 11,000 | - | - | Restricted Stock Unit | |
| Daniel J. Abdun-Nabi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2022 | 298 | 595 | - | - | Restricted Stock Unit | |
| Daniel J. Abdun-Nabi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2022 | 298 | 8,108 (0%) | 0% | - | Common Stock | |
| Zsolt Harsanyi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2022 | 298 | 595 | - | - | Restricted Stock Unit | |
| Zsolt Harsanyi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2022 | 298 | 4,607 (0%) | 0% | - | Common Stock | |
| Grady Grant | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2022 | 298 | 595 | - | - | Restricted Stock Unit | |
| Grady Grant | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2022 | 298 | 1,012 (0%) | 0% | - | Common Stock | |
| Barbara Lopez Kunz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2022 | 298 | 595 | - | - | Restricted Stock Unit | |
| Barbara Lopez Kunz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2022 | 298 | 1,012 (0%) | 0% | - | Common Stock | |
| So Young Kwon | SVP, GC and Corporate Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2022 | 1,833 | 3,667 | - | - | Restricted Stock Unit | |
| So Young Kwon | SVP, GC and Corporate Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2022 | 1,833 | 1,833 (0%) | 0% | - | Common Stock | |
| Marvin L. White | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2022 | 28,750 | 28,750 | - | - | Stock Option (right to buy) | |
| Jeffrey G. Lamothe | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2022 | 11,000 | 11,000 | - | - | Stock Option (right to buy) | |
| So Young Kwon | SVP, GC, and Corporate Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2022 | 11,000 | 11,000 | - | - | Stock Option (right to buy) | |
| Marvin L. White | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2022 | 4,792 | 9,583 | - | - | Restricted Stock Unit | |
| Marvin L. White | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2022 | 4,792 | 25,764 (0%) | 0% | - | Common Stock | |
| Jeffrey G. Lamothe | SVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2022 | 1,833 | 7,192 (0%) | 0% | - | Common Stock | |
| Jeffrey G. Lamothe | SVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2022 | 1,833 | 3,667 | - | - | Restricted Stock Unit | |
| Fuad El-Hibri | Director | Other type of transaction at price $ 0.00 per share. | 03 Dec 2021 | 7,373 | 7,373 (0%) | 0% | 0 | Common Stock | |
| Fuad El-Hibri | Director | Other type of transaction at price $ 0.00 per share. | 03 Dec 2021 | 9,819 | 9,819 (0%) | 0% | 0 | Common Stock | |
| Fuad El-Hibri | Director | Other type of transaction at price $ 0.00 per share. | 03 Dec 2021 | 107,807 | 107,807 (0%) | 0% | 0 | Common Stock | |
| Daniel J. Abdun-Nabi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2021 | 2,678 | 2,678 | - | - | Stock Option (right to buy) | |
| Daniel J. Abdun-Nabi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2021 | 893 | 893 | - | - | Restricted Stock Unit | |
| Fuad El-Hibri | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2021 | 2,678 | 2,678 | - | - | Stock Option (right to buy) | |
| Fuad El-Hibri | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2021 | 893 | 893 | - | - | Restricted Stock Unit | |
| Zsolt Harsanyi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2021 | 2,678 | 2,678 | - | - | Stock Option (right to buy) | |
| Zsolt Harsanyi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2021 | 893 | 893 | - | - | Restricted Stock Unit | |
| John Niederhuber | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2021 | 2,678 | 2,678 | - | - | Stock Option (right to buy) | |
| John Niederhuber | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2021 | 893 | 893 | - | - | Restricted Stock Unit | |
| Grady Grant | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2021 | 893 | 893 | - | - | Restricted Stock Unit | |
| Grady Grant | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2021 | 2,678 | 2,678 | - | - | Stock Option (right to buy) | |
| Barbara Lopez Kunz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2021 | 2,678 | 2,678 | - | - | Stock Option (right to buy) | |
| Barbara Lopez Kunz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2021 | 893 | 893 | - | - | Restricted Stock Unit | |
| So Young Kwon | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2021 | 5,500 | 5,500 | - | - | Restricted Stock Unit | |
| So Young Kwon | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2021 | 16,500 | 16,500 | - | - | Employee Stock Option (right to buy) | |
| Marvin L. White | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2021 | 14,375 | 14,375 | - | - | Restricted Stock Unit | |
| Marvin L. White | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2021 | 43,125 | 43,125 | - | - | Stock Option (right to buy) | |
| Jeffrey G. Lamothe | SVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2021 | 5,500 | 5,500 | - | - | Restricted Stock Unit | |
| Jeffrey G. Lamothe | SVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2021 | 16,500 | 16,500 | - | - | Stock Option (right to buy) | |
| Jane A. Gross | SVP & Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2021 | 16,500 | 16,500 | - | - | Stock Option (right to buy) | |
| Jane A. Gross | SVP & Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2021 | 5,500 | 5,500 | - | - | Restricted Stock Unit | |
| Daniel J. Abdun-Nabi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jul 2020 | 170 | 170 | - | - | Stock Option (right to buy) | |
| Daniel J. Abdun-Nabi | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Jul 2020 | 1,339 | 0 | - | - | Stock Option (right to buy) | |
| Daniel J. Abdun-Nabi | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Jul 2020 | 892 | 0 | - | - | Stock Option (right to buy) | |
| Daniel J. Abdun-Nabi | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Jul 2020 | 1,785 | 0 | - | - | Stock Option (right to buy) | |
| Daniel J. Abdun-Nabi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jul 2020 | 1,322 | 1,322 | - | - | Stock Option (right to buy) | |
| Fuad El-Hibri | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jul 2020 | 170 | 170 | - | - | Stock Option (right to buy) | |
| Fuad El-Hibri | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Jul 2020 | 1,339 | 0 | - | - | Stock Option (right to buy) | |
| Fuad El-Hibri | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Jul 2020 | 892 | 0 | - | - | Stock Option (right to buy) | |
| Fuad El-Hibri | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Jul 2020 | 1,785 | 0 | - | - | Stock Option (right to buy) | |
| Fuad El-Hibri | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jul 2020 | 1,322 | 1,322 | - | - | Stock Option (right to buy) | |
| Zsolt Harsanyi | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Jul 2020 | 892 | 0 | - | - | Stock Option (right to buy) | |
| Zsolt Harsanyi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jul 2020 | 170 | 170 | - | - | Stock Option (right to buy) | |
| Zsolt Harsanyi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jul 2020 | 1,322 | 1,322 | - | - | Stock Option (right to buy) | |
| Zsolt Harsanyi | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Jul 2020 | 1,785 | 0 | - | - | Stock Option (right to buy) | |
| Zsolt Harsanyi | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Jul 2020 | 1,339 | 0 | - | - | Stock Option (right to buy) | |
| Marvin L. White | Director, CEO and President | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Jul 2020 | 14,319 | 0 | - | - | Stock Option (right to buy) | |
| Marvin L. White | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jul 2020 | 4,813 | 4,813 | - | - | Stock Option (right to buy) | |
| Marvin L. White | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jul 2020 | 16,625 | 16,625 | - | - | Stock Option (right to buy) | |
| Marvin L. White | Director, CEO and President | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Jul 2020 | 10,828 | 0 | - | - | Stock Option (right to buy) | |
| Marvin L. White | Director, CEO and President | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Jul 2020 | 10,828 | 0 | - | - | Stock Option (right to buy) | |
| Marvin L. White | Director, CEO and President | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Jul 2020 | 5,414 | 0 | - | - | Stock Option (right to buy) | |
| Marvin L. White | Director, CEO and President | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Jul 2020 | 5,414 | 0 | - | - | Stock Option (right to buy) | |
| Marvin L. White | Director, CEO and President | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Jul 2020 | 2,545 | 0 | - | - | Stock Option (right to buy) | |
| John Niederhuber | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Jul 2020 | 1,339 | 0 | - | - | Stock Option (right to buy) | |
| John Niederhuber | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Jul 2020 | 892 | 0 | - | - | Stock Option (right to buy) | |
| John Niederhuber | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Jul 2020 | 1,785 | 0 | - | - | Stock Option (right to buy) | |
| John Niederhuber | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jul 2020 | 1,322 | 1,322 | - | - | Stock Option (right to buy) | |
| John Niederhuber | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jul 2020 | 170 | 170 | - | - | Stock Option (right to buy) | |
| Jeffrey G. Lamothe | SVP and CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Jul 2020 | 1,928 | 0 | - | - | Stock Option (right to buy) | |
| Jeffrey G. Lamothe | SVP and CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Jul 2020 | 3,128 | 0 | - | - | Stock Option (right to buy) | |
| Jeffrey G. Lamothe | SVP and CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Jul 2020 | 2,407 | 0 | - | - | Stock Option (right to buy) | |
| Jeffrey G. Lamothe | SVP and CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Jul 2020 | 2,407 | 0 | - | - | Stock Option (right to buy) | |
| Jeffrey G. Lamothe | SVP and CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Jul 2020 | 4,814 | 0 | - | - | Stock Option (right to buy) | |
| Jeffrey G. Lamothe | SVP and CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Jul 2020 | 4,814 | 0 | - | - | Stock Option (right to buy) | |
| Jeffrey G. Lamothe | SVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jul 2020 | 7,380 | 7,380 | - | - | Stock Option (right to buy) | |
| Jeffrey G. Lamothe | SVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jul 2020 | 2,140 | 2,140 | - | - | Stock Option (right to buy) | |
| Jeffrey G. Lamothe | SVP and CFO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Jul 2020 | 2,695 | 0 | - | - | Stock Option (right to buy) | |
| Grady Grant | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Jul 2020 | 892 | 0 | - | - | Stock Option (right to buy) | |
| Grady Grant | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Jul 2020 | 1,339 | 0 | - | - | Stock Option (right to buy) | |
| Grady Grant | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Jul 2020 | 1,785 | 0 | - | - | Stock Option (right to buy) | |
| Grady Grant | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jul 2020 | 1,322 | 1,322 | - | - | Stock Option (right to buy) | |
| Grady Grant | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jul 2020 | 170 | 170 | - | - | Stock Option (right to buy) | |
| Barbara Lopez Kunz | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Jul 2020 | 1,339 | 0 | - | - | Stock Option (right to buy) | |
| Barbara Lopez Kunz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jul 2020 | 170 | 170 | - | - | Stock Option (right to buy) | |
| Barbara Lopez Kunz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jul 2020 | 1,322 | 1,322 | - | - | Stock Option (right to buy) | |
| Barbara Lopez Kunz | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Jul 2020 | 1,785 | 0 | - | - | Stock Option (right to buy) | |
| Barbara Lopez Kunz | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Jul 2020 | 892 | 0 | - | - | Stock Option (right to buy) | |
| Randy Joe Maddux | SVP of Operations, CMO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Jul 2020 | 2,407 | 0 | - | - | Stock Option (right to buy) | |
| Randy Joe Maddux | SVP of Operations, CMO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Jul 2020 | 5,357 | 0 | - | - | Stock Option (right to buy) | |
| Randy Joe Maddux | SVP of Operations, CMO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Jul 2020 | 2,407 | 0 | - | - | Stock Option (right to buy) | |
| Randy Joe Maddux | SVP of Operations, CMO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Jul 2020 | 4,814 | 0 | - | - | Stock Option (right to buy) | |
| Randy Joe Maddux | SVP of Operations, CMO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Jul 2020 | 4,814 | 0 | - | - | Stock Option (right to buy) | |
| Randy Joe Maddux | SVP of Operations, CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jul 2020 | 6,423 | 6,423 | - | - | Stock Option (right to buy) | |
| Randy Joe Maddux | SVP of Operations, CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jul 2020 | 2,140 | 2,140 | - | - | Stock Option (right to buy) | |
| Jane A. Gross | SVP & Chief Scientific Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Jul 2020 | 4,814 | 0 | - | - | Stock Option (right to buy) | |
| Jane A. Gross | SVP & Chief Scientific Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Jul 2020 | 3,908 | 0 | - | - | Stock Option (right to buy) | |
| Jane A. Gross | SVP & Chief Scientific Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Jul 2020 | 2,407 | 0 | - | - | Stock Option (right to buy) | |
| Jane A. Gross | SVP & Chief Scientific Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Jul 2020 | 2,407 | 0 | - | - | Stock Option (right to buy) | |
| Jane A. Gross | SVP & Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jul 2020 | 2,140 | 2,140 | - | - | Stock Option (right to buy) | |
| Jane A. Gross | SVP & Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jul 2020 | 7,784 | 7,784 | - | - | Stock Option (right to buy) | |
| Jane A. Gross | SVP & Chief Scientific Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Jul 2020 | 4,814 | 0 | - | - | Stock Option (right to buy) | |
| Jane A. Gross | SVP & Chief Scientific Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Jul 2020 | 2,072 | 0 | - | - | Stock Option (right to buy) | |
| Jane A. Gross | SVP & Chief Scientific Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Jul 2020 | 2,779 | 0 | - | - | Stock Option (right to buy) | |
| Marvin L. White | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2020 | 303,200 | 303,200 | - | - | Stock Option (right to buy) | |
| Michael Adelman | SVP, Commercial Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2020 | 134,800 | 134,800 | - | - | Stock Option (right to buy) | |
| Jeffrey G. Lamothe | SVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2020 | 134,800 | 134,800 | - | - | Stock Option (right to buy) | |
| Randy Joe Maddux | SVP Operations, CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2020 | 134,800 | 134,800 | - | - | Stock Option (right to buy) | |
| Jane A. Gross | SVP & Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2020 | 134,800 | 134,800 | - | - | Stock Option (right to buy) | |
| Shawnte Mitchell | SVP, GC and Corporate Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Feb 2020 | 134,800 | 134,800 | - | - | Stock Option (right to buy) | |
| Marvin L. White | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Nov 2019 | 189,894 | 189,894 | - | - | Stock Option (right to buy) | |
| Michael Adelman | SVP, Commercial Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Nov 2019 | 114,247 | 114,247 | - | - | Stock Option (right to buy) | |
| Jeffrey G. Lamothe | SVP, CFO and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Nov 2019 | 135,384 | 135,384 | - | - | Stock Option (right to buy) | |
| Randy Joe Maddux | SVP Operations, CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Nov 2019 | 122,359 | 122,359 | - | - | Stock Option (right to buy) | |
| Jane A. Gross | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Nov 2019 | 122,982 | 122,982 | - | - | Stock Option (right to buy) | |
| Shawnte Mitchell | SVP, GC and Corporate Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Nov 2019 | 120,968 | 120,968 | - | - | Stock Option (right to buy) | |
| Randy Joe Maddux | SVP Operations, CMO | Purchase of securities on an exchange or from another person at price $ 0.76 per share. | 16 Aug 2019 | 25,000 | 75,000 (0%) | 0% | 0.8 | 19,000 | Common Stock |
| Fuad El-Hibri | None | Purchase of securities on an exchange or from another person at price $ 0.76 per share. | 12 Aug 2019 | 100,000 | 1,124,536 (2%) | 0% | 0.8 | 75,520 | Common Stock |
| Fuad El-Hibri | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.83 per share. | 29 Jul 2019 | 55,015 | 1,024,536 (2%) | 0% | 0.8 | 45,861 | Common Stock |
| Fuad El-Hibri | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.90 per share. | 23 Jul 2019 | 10,000 | 969,521 (2%) | 0% | 0.9 | 8,996 | Common Stock |
| Fuad El-Hibri | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.89 per share. | 22 Jul 2019 | 30,000 | 959,521 (2%) | 0% | 0.9 | 26,601 | Common Stock |
| Fuad El-Hibri | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.90 per share. | 19 Jul 2019 | 26,460 | 929,521 (2%) | 0% | 0.9 | 23,740 | Common Stock |
| Fuad El-Hibri | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.87 per share. | 18 Jul 2019 | 14,404 | 903,061 (1%) | 0% | 0.9 | 12,596 | Common Stock |
| Fuad El-Hibri | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.87 per share. | 17 Jul 2019 | 19,136 | 888,657 (1%) | 0% | 0.9 | 16,704 | Common Stock |
| Fuad El-Hibri | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.85 per share. | 16 Jul 2019 | 11,375 | 869,521 (1%) | 0% | 0.8 | 9,662 | Common Stock |
| Fuad El-Hibri | Director, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.85 per share. | 11 Jul 2019 | 14,691 | 858,146 (1%) | 0% | 0.8 | 12,454 | Common Stock |
| Fuad El-Hibri | None | Purchase of securities on an exchange or from another person at price $ 0.85 per share. | 10 Jul 2019 | 18,919 | 843,455 (1%) | 0% | 0.8 | 16,058 | Common Stock |
| Daniel J. Abdun-Nabi | None | Purchase of securities on an exchange or from another person at price $ 0.90 per share. | 25 Jun 2019 | 16,667 | 109,351 (0%) | 0% | 0.9 | 15,000 | Common Stock |
| Marvin L. White | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 0.88 per share. | 14 Jun 2019 | 50,000 | 293,603 (0%) | 0% | 0.9 | 44,000 | Common Stock |
| Barbara Lopez Kunz | None | Purchase of securities on an exchange or from another person at price $ 0.85 per share. | 10 Jun 2019 | 10,000 | 10,000 (0%) | 0% | 0.8 | 8,481 | Common Stock |
| Zsolt Harsanyi | None | Purchase of securities on an exchange or from another person at price $ 0.78 per share. | 07 Jun 2019 | 50,000 | 50,000 (0%) | 0% | 0.8 | 39,000 | Common Stock |
| Daniel J. Abdun-Nabi | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2019 | 25,000 | 25,000 | - | - | Option (right to buy) | |
| Fuad El-Hibri | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2019 | 25,000 | 25,000 | - | - | Option (right to buy) | |
| Zsolt Harsanyi | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2019 | 25,000 | 25,000 | - | - | Option (right to buy) | |
| John Niederhuber | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2019 | 25,000 | 25,000 | - | - | Option (right to buy) | |
| Grady Grant | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2019 | 25,000 | 25,000 | - | - | Option (right to buy) | |
| Barbara Lopez Kunz | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2019 | 25,000 | 25,000 | - | - | Option (right to buy) | |
| Randy Joe Maddux | Senior VP, Operations | Purchase of securities on an exchange or from another person at price $ 0.73 per share. | 31 May 2019 | 20,000 | 50,000 (0%) | 0% | 0.7 | 14,600 | Common Stock |
| Grady Grant | None | Purchase of securities on an exchange or from another person at price $ 0.80 per share. | 21 May 2019 | 10,000 | 10,000 (0%) | 0% | 0.8 | 7,970 | Common Stock |
| Marvin L. White | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 0.81 per share. | 20 May 2019 | 30,000 | 243,603 (0%) | 0% | 0.8 | 24,300 | Common Stock |
| Marvin L. White | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 0.78 per share. | 14 May 2019 | 10,000 | 213,603 (0%) | 0% | 0.8 | 7,800 | Common Stock |
| Scott C. Stromatt | Chief Medical Officer and SVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2019 | 67,400 | 67,400 | - | - | Stock Option (right to buy) | |
| Scott C. Stromatt | Chief Medical Officer and SVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2019 | 16,269 | 0 | - | - | Restricted Stock Unit | |
| Scott C. Stromatt | Chief Medical Officer and SVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2019 | 16,269 | 221,006 (0%) | 0% | - | Common Stock | |
| Scott C. Stromatt | Chief Medical Officer and SVP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.57 per share. | 28 Feb 2019 | 4,823 | 216,183 (0%) | 0% | 1.6 | 7,572 | Common Stock |
| Marvin L. White | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2019 | 151,600 | 151,600 | - | - | Stock Option (right to buy) | |
| Michael Adelman | SVP, Commercial Operations | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.57 per share. | 28 Feb 2019 | 2,395 | 70,426 (0%) | 0% | 1.6 | 3,760 | Common Stock |
| Michael Adelman | SVP, Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2019 | 7,318 | 0 | - | - | Restricted Stock Unit | |
| Michael Adelman | SVP, Commercial Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2019 | 67,400 | 67,400 | - | - | Stock Option (right to buy) | |
| Michael Adelman | SVP, Commercial Operations | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2019 | 7,318 | 72,821 (0%) | 0% | - | Common Stock | |
| Jeffrey G. Lamothe | SVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2019 | 7,318 | 0 | - | - | Restricted Stock Unit | |
| Jeffrey G. Lamothe | SVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2019 | 7,318 | 77,194 (0%) | 0% | - | Common Stock | |
| Jeffrey G. Lamothe | SVP and CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.57 per share. | 28 Feb 2019 | 2,170 | 75,024 (0%) | 0% | 1.6 | 3,407 | Common Stock |
| Jeffrey G. Lamothe | SVP and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2019 | 67,400 | 67,400 | - | - | Stock Option (right to buy) | |
| Randy Joe Maddux | SVP Operations, CMO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2019 | 67,400 | 67,400 | - | - | Stock Option (right to buy) | |
| Jane A. Gross | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2019 | 9,138 | 112,293 (0%) | 0% | - | Common Stock | |
| Jane A. Gross | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.57 per share. | 28 Feb 2019 | 2,710 | 109,583 (0%) | 0% | 1.6 | 4,255 | Common Stock |
| Jane A. Gross | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2019 | 67,400 | 67,400 | - | - | Stock Option (right to buy) | |
| Jane A. Gross | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2019 | 9,138 | 0 | - | - | Restricted Stock Unit | |
| Shawnte Mitchell | SVP, GC and Corporate Affairs | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2019 | 67,400 | 67,400 | - | - | Stock Option (right to buy) | |
| Shawnte Mitchell | SVP, GC and Corporate Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2019 | 6,787 | 82,539 (0%) | 0% | - | Common Stock | |
| Shawnte Mitchell | SVP, GC and Corporate Affairs | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.57 per share. | 28 Feb 2019 | 2,012 | 80,527 (0%) | 0% | 1.6 | 3,159 | Common Stock |
| Shawnte Mitchell | SVP, GC and Corporate Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2019 | 6,787 | 0 | - | - | Restricted Stock Unit | |
| Randy Joe Maddux | SVP Operations | Purchase of securities on an exchange or from another person at price $ 2.37 per share. | 06 Dec 2018 | 5,000 | 30,000 (0%) | 0% | 2.4 | 11,850 | Common Stock |
| Marvin L. White | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 2.38 per share. | 04 Dec 2018 | 10,000 | 203,603 (0%) | 0% | 2.4 | 23,800 | Common Stock |
| Shawnte Mitchell | SVP, GC and Corporate Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Aug 2018 | 1,630 | 6,787 | - | - | Restricted Stock Units | |
| Shawnte Mitchell | SVP, GC and Corporate Affairs | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.50 per share. | 09 Aug 2018 | 383 | 75,752 (0%) | 0% | 4.5 | 1,724 | Common Stock |
| Shawnte Mitchell | SVP, GC and Corporate Affairs | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Aug 2018 | 1,630 | 76,135 (0%) | 0% | 0 | Common Stock | |
| Daniel J. Abdun-Nabi | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2018 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Fuad El-Hibri | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2018 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Zsolt Harsanyi | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2018 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| John Niederhuber | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2018 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Grady Grant | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2018 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Barbara Lopez Kunz | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2018 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | |
| Marvin L. White | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.61 per share. | 21 May 2018 | 8,373 | 193,603 (0%) | 0% | 5.6 | 46,973 | Common Stock |
| Marvin L. White | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2018 | 35,644 | 201,976 (0%) | 0% | 0 | Common Stock | |
| Marvin L. White | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 May 2018 | 35,644 | 0 | - | - | Restricted Unit Stock | |
| Marvin L. White | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 2.93 per share. | 19 Mar 2018 | 100,000 | 166,332 (0%) | 0% | 2.9 | 293,000 | Common Stock |
| Scott C. Stromatt | Chief Medical Officer and SVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2018 | 67,400 | 67,400 | - | - | Employee Stock Options (Right to Buy) | |
| Scott C. Stromatt | Chief Medical Officer and SVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Mar 2018 | 13,892 | 16,269 | - | - | Restricted Stock Unit | |
| Scott C. Stromatt | Chief Medical Officer and SVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Mar 2018 | 13,892 | 204,737 (0%) | 0% | 0 | Common Stock | |
| Marvin L. White | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2018 | 151,600 | 151,600 | - | - | Employee Stock Options (Right to Buy) | |
| Jeffrey G. Lamothe | SVP, CFO and Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Mar 2018 | 6,747 | 71,459 (0%) | 0% | 0 | Common Stock | |
| Jeffrey G. Lamothe | SVP, CFO and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2018 | 67,400 | 67,400 | - | - | Employee Stock Options (Right to Buy) | |
| Jeffrey G. Lamothe | SVP, CFO and Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Mar 2018 | 6,747 | 7,318 | - | - | Restricted Stock Unit | |
| Jeffrey G. Lamothe | SVP, CFO and Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.13 per share. | 09 Mar 2018 | 1,583 | 69,876 (0%) | 0% | 3.1 | 4,955 | Common Stock |
| Randy Joe Maddux | Senior VP, Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2018 | 67,400 | 67,400 | - | - | Employee Stock Options (Right to Buy) | |
| Jane A. Gross | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Mar 2018 | 9,728 | 105,437 (0%) | 0% | 0 | Common Stock | |
| Jane A. Gross | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.13 per share. | 09 Mar 2018 | 2,282 | 103,155 (0%) | 0% | 3.1 | 7,143 | Common Stock |
| Jane A. Gross | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Mar 2018 | 9,728 | 9,138 | - | - | Restricted Stock Unit | |
| Jane A. Gross | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2018 | 67,400 | 67,400 | - | - | Employee Stock Options (Right to Buy) | |
| Scott C. Stromatt | Chief Medical Officer and SVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2018 | 16,269 | 190,845 (0%) | 0% | 0 | Common Stock | |
| Scott C. Stromatt | Chief Medical Officer and SVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2018 | 16,269 | 30,161 | - | - | Restricted Stock Unit | |
| Jeffrey G. Lamothe | SVP, CFO and Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2018 | 7,320 | 66,429 (0%) | 0% | 0 | Common Stock | |
| Jeffrey G. Lamothe | SVP, CFO and Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2018 | 7,320 | 14,065 | - | - | Restricted Stock Unit | |
| Jeffrey G. Lamothe | SVP, CFO and Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.04 per share. | 01 Mar 2018 | 1,717 | 64,712 (0%) | 0% | 3.0 | 5,220 | Common Stock |
| Jane A. Gross | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2018 | 9,140 | 95,709 (0%) | 0% | 0 | Common Stock | |
| Jane A. Gross | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2018 | 9,140 | 18,866 | - | - | Restricted Stock Unit | |
| Randy Joe Maddux | Senior VP, Operations | Purchase of securities on an exchange or from another person at price $ 2.76 per share. | 15 Nov 2017 | 25,000 | 25,000 (0%) | 0% | 2.8 | 69,000 | Common Stock |
| Scott C. Stromatt | Chief Medical Officer and SVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2017 | 78,123 | 73,811 | - | - | Restricted Stock Unit | |
| Scott C. Stromatt | Chief Medical Officer and SVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2017 | 78,123 | 147,195 (0%) | 0% | 0 | Common Stock | |
| Jane A. Gross | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2017 | 38,093 | 46,142 | - | - | Restricted Stock Unit | |
| Jane A. Gross | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2017 | 38,093 | 78,509 (0%) | 0% | 0 | Common Stock | |
| Jane A. Gross | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.83 per share. | 01 Aug 2017 | 10,076 | 68,433 (0%) | 0% | 1.8 | 18,439 | Common Stock |
| Daniel J. Abdun-Nabi | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2017 | 12,500 | 12,500 | - | - | Employee Stock Option (right to buy) | |
| Fuad El-Hibri | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2017 | 12,500 | 12,500 | - | - | Employee Stock Option (right to buy) | |
| Scott C. Stromatt | Chief Medical Officer and SVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2017 | 33,700 | 33,700 | - | - | Employee Stock Option (right to buy) | |
| Zsolt Harsanyi | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2017 | 12,500 | 12,500 | - | - | Employee Stock Option (right to buy) | |
| Marvin L. White | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2017 | 75,800 | 75,800 | - | - | Employee Stock Option (right to buy) | |
| John Niederhuber | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2017 | 12,500 | 12,500 | - | - | Employee Stock Option (right to buy) | |
| Jeffrey G. Lamothe | SVP, CFO and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2017 | 33,700 | 33,700 | - | - | Employee Stock Option (right to buy) | |
| Grady Grant | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2017 | 12,500 | 12,500 | - | - | Employee Stock Option (right to buy) | |
| Barbara Lopez Kunz | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2017 | 12,500 | 12,500 | - | - | Employee Stock Option (right to buy) | |
| Randy Joe Maddux | Senior VP, Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2017 | 33,700 | 33,700 | - | - | Employee Stock Option (right to buy) | |
| Jane A. Gross | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2017 | 33,700 | 33,700 | - | - | Employee Stock Option (right to buy) | |
| Marvin L. White | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 May 2017 | 35,643 | 53,472 | - | - | Restricted Stock Unit | |
| Marvin L. White | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 May 2017 | 17,828 | 35,644 | - | - | Restricted Stock Unit | |
| Marvin L. White | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 May 2017 | 17,828 | 66,332 (0%) | 0% | 0 | Common Stock | |
| Marvin L. White | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 May 2017 | 35,643 | 48,504 (0%) | 0% | 0 | Common Stock | |
| Scott C. Stromatt | Chief Medical Officer and SVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2017 | 24,836 | 75,642 (0%) | 0% | 0 | Common Stock | |
| Scott C. Stromatt | Chief Medical Officer and SVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2017 | 16,269 | 190,672 | - | - | Restricted Stock Unit | |
| Scott C. Stromatt | Chief Medical Officer and SVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2017 | 13,902 | 176,770 | - | - | Restricted Stock Unit | |
| Scott C. Stromatt | Chief Medical Officer and SVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2017 | 24,836 | 151,934 | - | - | Restricted Stock Unit | |
| Scott C. Stromatt | Chief Medical Officer and SVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2017 | 16,269 | 45,894 (0%) | 0% | 0 | Common Stock | |
| Scott C. Stromatt | Chief Medical Officer and SVP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.02 per share. | 01 Mar 2017 | 5,312 | 40,582 (0%) | 0% | 2.0 | 10,730 | Common Stock |
| Scott C. Stromatt | Chief Medical Officer and SVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2017 | 13,902 | 54,484 (0%) | 0% | 0 | Common Stock | |
| Scott C. Stromatt | Chief Medical Officer and SVP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.80 per share. | 01 Mar 2017 | 3,678 | 50,806 (0%) | 0% | 1.8 | 6,620 | Common Stock |
| Scott C. Stromatt | Chief Medical Officer and SVP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.78 per share. | 01 Mar 2017 | 6,570 | 69,072 (0%) | 0% | 1.8 | 11,695 | Common Stock |
| Jeffrey G. Lamothe | SVP, CFO and Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2017 | 18,863 | 46,725 | - | - | Restricted Stock Unit | |
| Jeffrey G. Lamothe | SVP, CFO and Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.78 per share. | 01 Mar 2017 | 4,990 | 41,284 (0%) | 0% | 1.8 | 8,882 | Common Stock |
| Jeffrey G. Lamothe | SVP, CFO and Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2017 | 18,863 | 46,274 (0%) | 0% | 0 | Common Stock | |
| Jeffrey G. Lamothe | SVP, CFO and Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.78 per share. | 01 Mar 2017 | 1,785 | 27,411 (0%) | 0% | 1.8 | 3,177 | Common Stock |
| Jeffrey G. Lamothe | SVP, CFO and Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2017 | 7,320 | 24,386 (0%) | 0% | 0 | Common Stock | |
| Jeffrey G. Lamothe | SVP, CFO and Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.02 per share. | 01 Mar 2017 | 1,936 | 22,450 (0%) | 0% | 2.0 | 3,911 | Common Stock |
| Jeffrey G. Lamothe | SVP, CFO and Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2017 | 6,746 | 29,196 (0%) | 0% | 0 | Common Stock | |
| Jeffrey G. Lamothe | SVP, CFO and Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2017 | 7,320 | 72,334 | - | - | Restricted Stock Unit | |
| Jeffrey G. Lamothe | SVP, CFO and Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2017 | 6,746 | 65,588 | - | - | Restricted Stock Unit | |
| Jane A. Gross | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2017 | 9,727 | 98,741 | - | - | Restricted Stock Unit | |
| Jane A. Gross | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2017 | 9,140 | 25,011 (0%) | 0% | 0 | Common Stock | |
| Jane A. Gross | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.02 per share. | 01 Mar 2017 | 2,148 | 22,593 (0%) | 0% | 2.0 | 4,339 | Common Stock |
| Jane A. Gross | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2017 | 9,727 | 32,320 (0%) | 0% | 0 | Common Stock | |
| Jane A. Gross | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.80 per share. | 01 Mar 2017 | 2,573 | 29,747 (0%) | 0% | 1.8 | 4,631 | Common Stock |
| Jane A. Gross | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2017 | 14,506 | 44,253 (0%) | 0% | 0 | Common Stock | |
| Jane A. Gross | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.78 per share. | 01 Mar 2017 | 3,837 | 40,416 (0%) | 0% | 1.8 | 6,830 | Common Stock |
| Jane A. Gross | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2017 | 14,506 | 84,235 | - | - | Restricted Stock Unit | |
| Jane A. Gross | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2017 | 9,140 | 108,468 | - | - | Restricted Stock Unit | |
| Scott C. Stromatt | Chief Medical Officer and SVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2017 | 33,700 | 236,580 | - | - | Stock Option (right to buy) | |
| Marvin L. White | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2017 | 75,800 | 311,918 | - | - | Stock Option (right to buy) | |
| Jeffrey G. Lamothe | SVP, CFO and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2017 | 33,700 | 142,232 | - | - | Stock Option (right to buy) | |
| Randy Joe Maddux | Senior VP, Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2017 | 33,700 | 108,700 | - | - | Stock Option (right to buy) | |
| Jane A. Gross | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2017 | 33,700 | 156,339 | - | - | Stock Option (right to buy) | |
| Scott C. Stromatt | Chief Medical Officer and SVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2017 | 27,381 | 29,625 (0%) | 0% | 0 | Common Stock | |
| Scott C. Stromatt | Chief Medical Officer and SVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2017 | 27,381 | 206,941 | - | - | Restricted Stock Unit | |
| Jeffrey G. Lamothe | SVP, CFO and Treasurer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.92 per share. | 03 Feb 2017 | 8,274 | 17,066 (0%) | 0% | 1.9 | 15,886 | Common Stock |
| Jeffrey G. Lamothe | SVP, CFO and Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2017 | 25,340 | 79,654 | - | - | Restricted Stock Unit | |
| Jeffrey G. Lamothe | SVP, CFO and Treasurer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2017 | 25,340 | 25,340 (0%) | 0% | 0 | Common Stock | |
| Jane A. Gross | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2017 | 18,135 | 117,608 | - | - | Restricted Stock Unit | |
| Jane A. Gross | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.92 per share. | 03 Feb 2017 | 5,922 | 15,871 (0%) | 0% | 1.9 | 11,370 | Common Stock |
| Jane A. Gross | See Remarks | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2017 | 18,135 | 21,793 (0%) | 0% | 0 | Common Stock | |
| Fuad El-Hibri | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2016 | 18,750 | 18,750 | - | - | Stock Option (right to buy) | |
| Scott C. Stromatt | Chief Medical Officer and SVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2016 | 78,123 | 234,322 | - | - | Restricted Stock Unit | |
| Scott C. Stromatt | Chief Medical Officer and SVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2016 | 54,762 | 54,762 | - | - | Restricted Stock Unit | |
| Zsolt Harsanyi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2016 | 18,750 | 18,750 | - | - | Stock Option (right to buy) | |
| Marvin L. White | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2016 | 200,475 | 236,118 | - | - | Stock Option (right to buy) | |
| John Niederhuber | Director | Purchase of securities on an exchange or from another person at price $ 0.91 per share. | 03 Aug 2016 | 714 | 1,516 (0%) | 0% | 0.9 | 650 | Common Stock |
| John Niederhuber | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Aug 2016 | 298 | 1,814 (0%) | 0% | - | Common Stock | |
| John Niederhuber | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Aug 2016 | 298 | 595 | - | - | Restricted Stock Unit | |
| John Niederhuber | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2016 | 18,750 | 18,750 | - | - | Stock Option (right to buy) | |
| Jeffrey G. Lamothe | SVP, CFO and Treasurer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2016 | 50,680 | 104,994 | - | - | Restricted Stock Unit | |
| Grady Grant | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2016 | 18,750 | 18,750 | - | - | Stock Option (right to buy) | |
| Barbara Lopez Kunz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2016 | 18,750 | 18,750 | - | - | Stock Option (right to buy) |